1. Home
  2. CTY vs JFR Comparison

CTY vs JFR Comparison

Compare CTY & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTY

City Therapeutics Inc. Common Stock

N/A

Current Price

$17.55

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Nuveen Floating Rate Income Fund

JFR

Nuveen Floating Rate Income Fund

N/A

Current Price

$7.10

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CTY
JFR
Founded
2023
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2026
2004

Fundamental Metrics

Financial Performance
Metric
CTY
JFR
Price
$17.55
$7.10
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $37.33
N/A
AVG Volume (30 Days)
250.4K
★ 724.9K
Earning Date
12-01-2026
01-01-0001
Dividend Yield
N/A
★ 11.31%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$62.96
N/A
Revenue Next Year
$7.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.81
$7.07
52 Week High
$22.65
$8.00

Technical Indicators

Market Signals
Indicator
CTY
JFR
Relative Strength Index (RSI) 41.04 37.49
Support Level $16.12 $7.09
Resistance Level $21.98 $7.45
Average True Range (ATR) 2.35 0.08
MACD -0.15 -0.01
Stochastic Oscillator 25.44 9.09

Price Performance

Historical Comparison
CTY
JFR

About CTY City Therapeutics Inc. Common Stock

City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.

About JFR Nuveen Floating Rate Income Fund

Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests the majority of its managed assets in secured senior loans and unsecured senior loans, which unsecured senior Loans are generally, at the time of investment, investment grade quality.

Share on Social Networks: